BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11701384)

  • 1. The effect of the leucopyrokinin analogue: [2-8]-leucopyrokinin on central opioid receptors in rats.
    Rykaczewska-Czerwińska M; Konopińska D; Plech A
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Nov; 130(3):271-9. PubMed ID: 11701384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive properties of FR140423 mediated through spinal delta-, but not mu- and kappa-, opioid receptors.
    Ochi T; Fujii T; Motoyama Y; Goto T
    Eur J Pharmacol; 1999 Sep; 380(2-3):73-9. PubMed ID: 10513565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
    Matsuzawa S; Suzuki T; Misawa M; Nagase H
    Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
    Gao L; Yu LC
    Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of multiple opioid receptors in the potentiation of reward by food restriction.
    Carr KD; Papadouka V
    Brain Res; 1994 Mar; 639(2):253-60. PubMed ID: 8205479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
    Salmi P; Kela J; Arvidsson U; Wahlestedt C
    Eur J Pharmacol; 2003 Jan; 458(1-2):101-6. PubMed ID: 12498912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of opioid system in modulation of pain sensitivity under conditons of low and high environmental temperature.
    Kolotilova AB; Guzevatikh LS; Valujskikh DV; Emel'yanova TG
    Bull Exp Biol Med; 2008 Jun; 145(6):707-9. PubMed ID: 19110556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucopyrokinin (LPK) analog [d-Ala(5)]-[2-8]-LPK inhibits LPK-induced analgesia in rats.
    Plech A; Rykaczewska-Czerwińska M; Konopińska D
    Peptides; 2004 Jun; 25(6):1005-11. PubMed ID: 15203248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociception after intracerebroventricular administration of naltrindole in the mouse.
    Stapelfeld A; Hammond DL; Rafferty MF
    Eur J Pharmacol; 1992 Apr; 214(2-3):273-6. PubMed ID: 1325358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity.
    Mellon RD; Bayer BM
    Brain Res; 1998 Apr; 789(1):56-67. PubMed ID: 9602057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid receptors and acetaminophen (paracetamol).
    Raffa RB; Walker EA; Sterious SN
    Eur J Pharmacol; 2004 Oct; 503(1-3):209-10. PubMed ID: 15496316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of opioid receptor subtypes in antinociceptive actions of supraspinally-administered mitragynine in mice.
    Thongpradichote S; Matsumoto K; Tohda M; Takayama H; Aimi N; Sakai S; Watanabe H
    Life Sci; 1998; 62(16):1371-8. PubMed ID: 9585164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociception.
    Hutcheson DM; Sánchez-Blazquez P; Rodriguez-Diaz M; Garzon J; Schmidhammer H; Borsodi A; Roques BP; Maldonado R
    Eur J Pharmacol; 1999 Oct; 383(1):29-37. PubMed ID: 10556678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
    Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
    Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
    Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
    Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L; Noviello L; Noviello V
    Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid system mediated anti-nociceptive effect of agomelatine in mice.
    Kasap M; Can ÖD
    Life Sci; 2016 Oct; 163():55-63. PubMed ID: 27590609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
    Kamei J; Morita K; Saitoh A; Nagase H
    Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB; Welch SP
    Eur J Pharmacol; 1999 Dec; 385(2-3):119-27. PubMed ID: 10607867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.